Rescuing chemotaxis of the anticancer agent Salmonella enterica serovar Typhimurium VNP20009

Journal of Biotechnology

Volumn 211, Issue , 2015, Pages 117-120

  Broadway, Katherine M ^a   Denson, Elizabeth A P ^a   Jensen, Roderick V ^a   Scharf, Birgit E ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Bacterial cancer therapy; Chemotaxis; Flagellar motor; Tumor colonizing bacteria

Indexed keywords

MUTAGENESIS; PLANTS (BOTANY); PROTEINS; RESTORATION; SALMONELLA; TUMORS;

ANTI-CANCER AGENTS; CANCER THERAPY; CHEMOTAXIS; FLAGELLAR MOTORS; GENOME SEQUENCING; RESPONSE REGULATORS; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SINGLE-NUCLEOTIDE POLYMORPHISMS;

BIOCHEMISTRY;

ANTINEOPLASTIC AGENT; ASPARTIC ACID; CHEY PROTEIN; PROLINE; UNCLASSIFIED DRUG; VNP 20009;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; CHEMOTAXIS; COMPLEX FORMATION; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; NONHUMAN; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE; CYTOLOGY; DNA SEQUENCE; DRUG EFFECTS; GENETICS; MUTATION; SALMONELLA ENTERICA;

BACTERIA (MICROORGANISMS); SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM;

ANTINEOPLASTIC AGENTS; CHEMOTAXIS; MUTATION; PHENOTYPE; SALMONELLA ENTERICA; SEQUENCE ANALYSIS, DNA;

EID: 84938873860     PISSN: 01681656     EISSN: 18734863     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2015.07.010     Document Type: Article

References (33)

1. Adler J. A method for measuring chemotaxis and use of the method to determine optimum conditions for chemotaxis by Escherichia coli. J. Gen. Microbiol. 1973, 74:77-91.
2. Baker M.D., Wolanin P.M., Stock J.B. Signal transduction in bacterial chemotaxis. Bioessays 2006, 28:9-22.
3. Bermudes D., Low B., Pawelek J.M. Tumor-targeted Salmonella: strain development and expression of the HSV-tK effector gene. Methods Mol. Med. 2000, 35:419-436.
4. Bren A., Eisenbach M. The N terminus of the flagellar switch protein, FliM, is the binding domain for the chemotactic response regulator, CheY. J. Mol. Biol. 1998, 278:507-514.
5. Broadway K.M., Modise T., Jensen R.V., Scharf B.E. Complete genome sequence of Salmonella enterica serovar Typhimurium VNP20009, a strain engineered for tumor targeting. J Biotechnol 2014, 192(Pt A):177-178.
6. Choe E., Kazmierczak R.A., Eisenstark A. Phenotypic evolution of therapeutic Salmonella enterica serovar Typhimurium after invasion of TRAMP mouse prostate tumor. MBio 2014, 5. e01182-e01114.
7. Clairmont C., Lee K.C., Pike J., Ittensohn M., Low K.B., Pawelek J., Bermudes D., Brecher S.M., Margitich D., Turnier J., Li Z., Luo X., King I., Zheng L.M. Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium. J. Infect. Dis. 2000, 181:1996-2002.
8. Crull K., Bumann D., Weiss S. Influence of infection route and virulence factors on colonization of solid tumors by Salmonella enterica serovar Typhimurium. FEMS Immunol. Med. Microbiol. 2011, 62:75-83.
9. Datsenko K.A., Wanner B.L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:6640-6645.
10. Frahm M., Felgner S., Kocijancic D., Rohde M., Hensel M., Curtiss R., 3rd, Erhardt M., Weiss S. Efficiency of conditionally attenuated Salmonella enterica serovar Typhimurium in bacterium-mediated tumor therapy. MBio 2015, 6.
11. Karlinsey J.E. Lambda-Red genetic engineering in Salmonella enterica serovar Typhimurium. Methods Enzymol. 2007, 421:199-209.
12. Kasinskas R.W., Forbes N.S. Salmonella typhimurium specifically chemotax and proliferate in heterogeneous tumor tissue in vitro. Biotechnol. Bioeng. 2006, 94:710-721.
13. Kasinskas R.W., Forbes N.S. Salmonella typhimurium lacking ribose chemoreceptors localize in tumor quiescence and induce apoptosis. Cancer Res. 2007, 67:3201-3209.
14. Lazova M.D., Butler M.T., Shimizu T.S., Harshey R.M. Salmonella chemoreceptors McpB and McpC mediate a repellent response to -cystine: a potential mechanism to avoid oxidative conditions. Mol. Microbiol. 2012, 84:697-711.
15. Low K.B., Ittensohn M., Le T., Platt J., Sodi S., Amoss M., Ash O., Carmichael E., Chakraborty A., Fischer J., Lin S.L., Luo X., Miller S.I., Zheng L., King I., Pawelek J.M., Bermudes D. Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo. Nat. Biotechnol. 1999, 17:37-41.
16. McEvoy M.M., Bren A., Eisenbach M., Dahlquist F.W. Identification of the binding interfaces on CheY for two of its targets, the phosphatase CheZ and the flagellar switch protein FliM. J. Mol. Biol. 1999, 289:1423-1433.
17. Mohari B., Licata N.A., Kysela D.T., Merritt P.M., Mukhopadhay S., Brun Y.V., Setayeshgar S., Fuqua C. Novel pseudotaxis mechanisms improve migration of straight-swimming bacterial mutants through a porous environment. MBio 2015, 6:e00005.
18. Morimoto Y.V., Minamino T. Structure and function of the bi-directional bacterial flagellar motor. Biomolecules 2014, 4:217-234.
19. Murray S.R., Bermudes D., de Felipe K.S., Low K.B. Extragenic suppressors of growth defects in msbB Salmonella. J. Bacteriol. 2001, 183:5554-5561.
20. Murray S.R., de Felipe K.S., Obuchowski P.L., Pike J., Bermudes D., Low K.B. Hot spot for a large deletion in the 18- to 19-centisome region confers a multiple phenotype in Salmonella enterica serovar Typhimurium strain ATCC 14028. J. Bacteriol. 2004, 186:8516-8523.
21. Pawelek J.M., Low K.B., Bermudes D. Bacteria as tumour-targeting vectors. Lancet Oncol. 2003, 4:548-556.
22. Shukla D., Zhu X.Y., Matsumura P. Flagellar motor-switch binding face of CheY and the biochemical basis of suppression by CheY mutants that compensate for motor-switch defects in Escherichia coli. J. Biol. Chem. 1998, 273:23993-23999.
23. Silversmith R.E., Bourret R.B. Throwing the switch in bacterial chemotaxis. Trends Microbiol. 1999, 7:16-22.
24. Sockett H., Yamaguchi S., Kihara M., Irikura V.M., Macnab R.M. Molecular analysis of the flagellar switch protein FliM of Salmonella typhimurium. J. Bacteriol. 1992, 174:793-806.
25. Stock A.M., Mottonen J.M., Stock J.B., Schutt C.E. Three-dimensional structure of CheY, the response regulator of bacterial chemotaxis. Nature 1989, 337:745-749.
26. Stritzker J., Weibel S., Seubert C., Gotz A., Tresch A., van Rooijen N., Oelschlaeger T.A., Hill P.J., Gentschev I., Szalay A.A. Enterobacterial tumor colonization in mice depends on bacterial metabolism and macrophages but is independent of chemotaxis and motility. Int. J. Med. Microbiol. IJMM 2010, 300:449-456.
27. Terashima H., Kojima S., Homma M. Flagellar motility in bacteria structure and function of flagellar motor. Int. Rev. Cell Mol. Biol. 2008, 270:39-85.
28. Thamm D.H., Kurzman I.D., King I., Li Z., Sznol M., Dubielzig R.R., Vail D.M., MacEwen E.G. Systemic administration of an attenuated, tumor-targeting Salmonella typhimurium to dogs with spontaneous neoplasia: phase I evaluation. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 2005, 11:4827-4834.
29. Toley B.J., Forbes N.S. Motility is critical for effective distribution and accumulation of bacteria in tumor tissue. Integr. Biol. (Camb) 2012, 4:165-176.
30. Toso J.F., Gill V.J., Hwu P., Marincola F.M., Restifo N.P., Schwartzentruber D.J., Sherry R.M., Topalian S.L., Yang J.C., Stock F., Freezer L.J., Morton K.E., Seipp C., Haworth L., Mavroukakis S., White D., MacDonald S., Mao J., Sznol M., Rosenberg S.A. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J. Clin. Oncol. 2002, 20:142-152.
31. Volz K., Matsumura P. Crystal structure of Escherichia coli CheY refined at 1.7-A resolution. J. Biol. Chem. 1991, 266:15511-15519.
32. Wolfe A.J., Berg H.C. Migration of bacteria in semisolid agar. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:6973-6977.
33. Zhang M., Forbes N.S. Trg-deficient Salmonella colonize quiescent tumor regions by exclusively penetrating or proliferating. J. Control Release 2015, 199:180-189.